Search research articles
Contact Us
Filters
Showing results (11-20 of 138) with videos related to
Page
of 14
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 26, 2024
Accelerating CAR-T Cell Therapies with Small-Molecule Inhibitors
Katrin Mestermann, Andoni Garitano-Trojaola, Michael Hudecek
Current Opinion in Oncology
|
July 14, 2020
New targets and technologies for CAR-T cells
Fabian Freitag, Marius Maucher, Zeno Riester, et al.
Journal of Hepatology
|
June 22, 2025
Chimeric antigen receptor (CAR) T-cell therapy: Engineering immune cells to treat liver diseases
Elmar Jaeckel, Scott L Friedman, Michael Hudecek, et al.
Journal of Visualized Experiments : Jove
|
October 21, 2024
Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System
Maximilian Bauser, Hermann Einsele, Jürgen Löffler, et al.
Expert Review of Hematology
|
November 19, 2010
Adoptive T-cell therapy for B-cell malignancies
Michael Hudecek, Larry D Anderson, Tetsuya Nishida, et al.
Current Opinion in Immunology
|
July 24, 2012
Engineered T cells for anti-cancer therapy
Cameron J Turtle, Michael Hudecek, Michael C Jensen, et al.
Frontiers in Immunology
|
November 15, 2021
T-Cell Metabolism in Graft <i>Versus</i> Host Disease
Franziska Karl, Michael Hudecek, Friederike Berberich-Siebelt, et al.
Oncology Research and Treatment
|
March 16, 2025
Multi-Targeting CAR-T Cell Strategies to Overcome Immune Evasion in Lymphoid and Myeloid Malignancies
Jessica Peter, Fabio Toppeta, Alexandre Trubert, et al.
Current Opinion in Oncology
|
August 16, 2020
Overcoming key challenges in cancer immunotherapy with engineered T cells
Silvia Arcangeli, Katrin Mestermann, Justus Weber, et al.
Advances in Cell and Gene Therapy
|
November 14, 2018
CAR T cells targeting α<sub>v</sub>β<sub>3</sub> integrin are effective against advanced cancer in preclinical models
Lars Wallstabe, Andreas Mades, Silke Frenz, et al.
Page
of 14
Search research articles
Search
Showing results (11-20 of 138) with videos related to
Sort By:
Page
of 14
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 26, 2024
Accelerating CAR-T Cell Therapies with Small-Molecule Inhibitors
Katrin Mestermann, Andoni Garitano-Trojaola, Michael Hudecek
Current Opinion in Oncology
|
July 14, 2020
New targets and technologies for CAR-T cells
Fabian Freitag, Marius Maucher, Zeno Riester, et al.
Journal of Hepatology
|
June 22, 2025
Chimeric antigen receptor (CAR) T-cell therapy: Engineering immune cells to treat liver diseases
Elmar Jaeckel, Scott L Friedman, Michael Hudecek, et al.
Journal of Visualized Experiments : Jove
|
October 21, 2024
Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System
Maximilian Bauser, Hermann Einsele, Jürgen Löffler, et al.
Expert Review of Hematology
|
November 19, 2010
Adoptive T-cell therapy for B-cell malignancies
Michael Hudecek, Larry D Anderson, Tetsuya Nishida, et al.
Current Opinion in Immunology
|
July 24, 2012
Engineered T cells for anti-cancer therapy
Cameron J Turtle, Michael Hudecek, Michael C Jensen, et al.
Frontiers in Immunology
|
November 15, 2021
T-Cell Metabolism in Graft <i>Versus</i> Host Disease
Franziska Karl, Michael Hudecek, Friederike Berberich-Siebelt, et al.
Oncology Research and Treatment
|
March 16, 2025
Multi-Targeting CAR-T Cell Strategies to Overcome Immune Evasion in Lymphoid and Myeloid Malignancies
Jessica Peter, Fabio Toppeta, Alexandre Trubert, et al.
Current Opinion in Oncology
|
August 16, 2020
Overcoming key challenges in cancer immunotherapy with engineered T cells
Silvia Arcangeli, Katrin Mestermann, Justus Weber, et al.
Advances in Cell and Gene Therapy
|
November 14, 2018
CAR T cells targeting α<sub>v</sub>β<sub>3</sub> integrin are effective against advanced cancer in preclinical models
Lars Wallstabe, Andreas Mades, Silke Frenz, et al.
Page
of 14